Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Belfort – page 2

125 clinical trials in Belfort, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Belfort at a glance
125
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

125 trials in Belfort

Open in trial search

Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Oxygen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

IgA nephropathy

Recruiting

Study of felzartamab compared to placebo in adults with IgA nephropathy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Biogen Idec Research Limited

Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Les Hopitaux Universitaires De Strasbourg

Study of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Atacicept
  • Sponsor:Vera Therapeutics Inc.

Study on Digital Monitoring of Symptoms in Patients with Advanced Kidney Cancer Treated with Cabozantinib and Nivolumab

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Centre Francois Baclesse

Study on the Effectiveness and Safety of Tagraxofusp and Venetoclax for Adults with Untreated Blastic Plasmacytoid Dendritic Cell Neoplasm

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tagraxofusp
  • Sponsor:French Innovative Leukemia Organization

Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Intergroupe Francophone Du Myelome

Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Et Universitaire De Limoges

Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Unicancer

Study on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Intergroupe Francophone De Cancerologie Thoracique

Study on Regorafenib with Cyclophosphamide, Capecitabine, and Aspirin for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Centre Hospitalier Regional Universitaire

Study on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:MPS-102
  • Sponsor:Fondazione Ricerca Traslazionale

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in Belfort

What the registry says about research in the country

01 Respiratory and Circulatory Physiology

The clinical research activity in Belfort focuses on a small but clearly targeted set of studies within Phenomena and Processes, especially Circulatory and Respiratory Physiological Phenomena. These trials are examining how treatments may improve patient outcomes in serious lung and blood-circulation-related conditions.

  • Research in Chronic pulmonary aspergillosis is assessing better control of persistent fungal lung disease
  • Studies in Septic shock are exploring ways to support critically ill patients with severe circulatory failure
  • Clinical work is aimed at comparing treatment effectiveness and improving patient survival and recovery

This area brings together respiratory and intensive care research, with a focus on evaluating whether new or combined approaches can provide stronger clinical benefit than standard care alone.

02 Pulmonary Infection and Antifungal Care

One line of research is centered on Chronic pulmonary aspergillosis, a long-term fungal infection affecting the lungs. The studies are designed to test whether adding another therapy can improve both clinical response and imaging results in patients with limited immune suppression.

  • Focus on persistent fungal lung infection and treatment response
  • Evaluation of whether combination therapy offers added benefit over standard antifungal care
  • Interest in both symptom improvement and radiological outcomes

These trials help clarify how best to manage a difficult respiratory condition where long-term control is often a challenge.

03 Critical Care and Septic Shock Research

Another study area examines Septic shock in mechanically ventilated patients, with attention on treatments that may improve outcomes in severe, refractory cases. The goal is to see whether an added supportive therapy can reduce mortality alongside standard critical care.

  • Research on severe infection-related shock and organ support
  • Assessment of adjunctive treatment for patients not responding well to usual care
  • Outcome focus on short-term survival in intensive care settings

This work supports efforts to strengthen treatment strategies for one of the most urgent emergencies in intensive care medicine.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.